Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Longeveron (LGVN)
NASDAQ:LGVN
Holding LGVN?
Track your performance easily
LGVN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.77 - $11.00
Previous CloseN/A
Volume215.49K
Average Volume (3M)327.20K
Market Cap
$26.11M
Enterprise Value$5.26M
Total Cash (Recent Filing)$4.03M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta2.07
Next Earnings
Mar 07, 2025EPS Estimate
-0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.33
Shares Outstanding13,352,770
10 Day Avg. Volume329,305
30 Day Avg. Volume327,202
Standard Deviation1.03
R-Squared0.00029
Alpha0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)14.03
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market Cap0.20
Enterprise Value/Revenue2.78
Enterprise Value/Gross Profit23.80
Enterprise Value/Ebitda-0.32
Forecast
1Y Price Target
$10.00Price Target Upside468.18% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Longeveron News
Options Prices
Currently, No data available
---
Ownership Overview
13.59% Insiders
0.63% Mutual Funds
0.20% Other Institutional Investors
84.50% Public Companies and Individual Investors
LGVN FAQ
What was Longeveron’s price range in the past 12 months?
Longeveron lowest stock price was $0.77 and its highest was $11.00 in the past 12 months.
What is Longeveron’s market cap?
Longeveron’s market cap is $26.11M.
When is Longeveron’s upcoming earnings report date?
Longeveron’s upcoming earnings report date is Mar 07, 2025 which is in 48 days.
How were Longeveron’s earnings last quarter?
Longeveron released its earnings results on Nov 12, 2024. The company reported -$0.34 earnings per share for the quarter, beating the consensus estimate of -$0.39 by $0.05.
Is Longeveron overvalued?
According to Wall Street analysts Longeveron’s price is currently Undervalued.
Does Longeveron pay dividends?
Longeveron does not currently pay dividends.
What is Longeveron’s EPS estimate?
Longeveron’s EPS estimate is -0.37.
How many shares outstanding does Longeveron have?
Longeveron has 13,352,770 shares outstanding.
What happened to Longeveron’s price movement after its last earnings report?
Longeveron reported an EPS of -$0.34 in its last earnings report, beating expectations of -$0.39. Following the earnings report the stock price went down -7.826%.
Which hedge fund is a major shareholder of Longeveron?
Currently, no hedge funds are holding shares in LGVN
---
Company Description
Longeveron
Longeveron LLC is a biotechnology company developing cellular therapies for specific aging-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and hypoplastic left heart syndrome (HLHS).
---
LGVN Earnings Call
Q2 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a largely positive outlook with significant milestones achieved in HLHS and Alzheimer's programs, financial growth, and a strategic focus on advancing stem cell therapies. However, challenges remain in Alzheimer's development and securing additional financing.Read More>---
LGVN Stock 12 Month Forecast
Average Price Target
$10.00
▲(468.18% Upside)
Technical Analysis
ADMA Biologics
―
Ocugen
―
Eloxx Pharmaceuticals
―
Cellectar Biosciences
―
180 Life Sciences
―
uniQure
―
Best Analysts Covering LGVN
1 Year
1 Year Success Rate
0/14 ratings generated profit
1 Year Average Return
-71.29%
reiterated a buy rating 5 months ago
Copying Michael Okunewitch's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -71.29% per trade.
---